| Q35833368 | Acute cytomegalovirus infection induces a subendothelial inflammation (endothelialitis) in the allograft vascular wall. A possible linkage with enhanced allograft arteriosclerosis. |
| Q33661571 | Are there markers to initiate treatment of chronic rejection? |
| Q26744665 | Bioactive Molecules Released From Cells Infected with the Human Cytomegalovirus |
| Q73279537 | CMV increases inflammation and accelerates chronic rejection in rat kidney allografts |
| Q35543009 | Cardiac allograft vasculopathy: central role of endothelial injury leading to transplant ???atheroma??? |
| Q37860476 | Chlamydia pneumoniae infection is not associated with chronic transplant dysfunction in a rat aortic allograft model |
| Q41141020 | Chronic allograft arteriosclerosis: contributing factors and molecular mechanisms in the light of experimental studies |
| Q33762113 | Coronary artery disease after heart transplantation and its relation to cytomegalovirus |
| Q36363303 | Cytomegalovirus CC chemokine promotes immune cell migration |
| Q33768702 | Cytomegalovirus and atherogenesis |
| Q34294809 | Cytomegalovirus infection and cardiac allograft vasculopathy |
| Q74428419 | Cytomegalovirus infection is associated with increased inflammation and severe bile duct damage in rat liver allografts |
| Q44676762 | Cytomegalovirus infection-enhanced chronic kidney allograft rejection is linked with intercellular adhesion molecule-1 expression |
| Q33762118 | Cytomegalovirus is involved in vascular pathology |
| Q34467148 | Cytomegalovirus-mediated upregulation of chemokine expression correlates with the acceleration of chronic rejection in rat heart transplants |
| Q63915277 | Driving cells into atherosclerotic lesions– a deleterious role for viral chemokine receptors? |
| Q33987842 | Emerging relations between infectious diseases and coronary artery disease and atherosclerosis. |
| Q40410947 | HHEX: A Crosstalker between HCMV Infection and Proliferation of VSMCs |
| Q33535928 | Heart allograft vascular disease: an obliterative vascular disease in transplanted hearts |
| Q44222407 | Histological lesions in vascular tissues of bovine herpes virus type 4-infected rabbits |
| Q35889716 | Human cytomegalovirus IE2 86-kilodalton protein binds p53 but does not abrogate G1 checkpoint function. |
| Q48096321 | Human cytomegalovirus infection and coronary heart disease: a systematic review |
| Q45190392 | Human cytomegalovirus infection leads to elevated levels of transplant arteriosclerosis in a humanized mouse aortic xenograft model |
| Q36747994 | Human cytomegalovirus secretome contains factors that induce angiogenesis and wound healing |
| Q37596537 | Human cytomegalovirus-specific CD4+-T-cell cytokine response induces fractalkine in endothelial cells |
| Q34568922 | IL-6 in human cytomegalovirus secretome promotes angiogenesis and survival of endothelial cells through the stimulation of survivin |
| Q33542770 | Immunologic and nonimmunologic risk factors of chronic rejection |
| Q40727899 | Induction of the RelB NF-kappaB subunit by the cytomegalovirus IE1 protein is mediated via Jun kinase and c-Jun/Fra-2 AP-1 complexes |
| Q34807471 | Infections and solid organ transplant rejection: a cause-and-effect relationship? |
| Q35796129 | Infrequency of cytomegalovirus genome in coronary arteriopathy of human heart allografts |
| Q37220021 | Mechanisms of cytomegalovirus-accelerated vascular disease: induction of paracrine factors that promote angiogenesis and wound healing |
| Q71558972 | Membrane related effects in endothelial cells induced by human cytomegalovirus |
| Q27478450 | Modulation of major histocompatibility complex antigen expression by viral infection |
| Q24520487 | Natural pathogens of laboratory mice, rats, and rabbits and their effects on research |
| Q43718500 | Prevention of cytomegalovirus infection-enhanced experimental obliterative bronchiolitis by antiviral prophylaxis or immunosuppression in rat tracheal allografts |
| Q34712927 | RCMV increases intimal hyperplasia by inducing inflammation, MCP-1 expression and recruitment of adventitial cells to intima |
| Q37222032 | Rat Cytomegalovirus Vaccine Prevents Accelerated Chronic Rejection in CMV-Naïve Recipients of Infected Donor Allograft Hearts |
| Q34364116 | RelB-p50 NF-kappa B complexes are selectively induced by cytomegalovirus immediate-early protein 1: differential regulation of Bcl-x(L) promoter activity by NF-kappa B family members |
| Q38779938 | The Cell Biology of Cytomegalovirus: Implications for Transplantation |
| Q36669956 | The aetiology and pathogenesis of chronic allograft nephropathy |
| Q45863859 | The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration |
| Q73219424 | The relative influence of antigen-dependent and independent factors for development and progression of chronic rejection |
| Q42839679 | Transformation of rabbit vascular smooth muscle cells by human cytomegalovirus morphological transforming region I |
| Q35834106 | Triple drug immunosuppression significantly reduces immune activation and allograft arteriosclerosis in cytomegalovirus-infected rat aortic allografts and induces early latency of viral infection |